The overexpression of miR-214 in ovarian cancer and the inhibition of PTEN expression reduce the activation of the AKT pathway, which promotes the phosphorylation of glycogen synthase kinase 3h (GSK3β) and p70 Ribosomal Protein S6 Kinase (p70S6K). This evidence concerns the gene AKT1 and ovarian cancer.